Verapamil, clarithromycin, and voriconazole are known inhibitors of the CYP3A4 and their administration increased plasma concentration of everolimus (40 ng/ml –110 ng/ml) and its toxicities like mucositis, acute kidney injury, proteinuria or nephrotic syndrome. This evidence concerns the gene CYP3A4 and mucositis.